GTM Strategy

The Boardroom Blind Spot: How Sales and Marketing Misalignment Erodes EBITDA

Why the gap between your commercial teams is costing you more than you think, and what a CEO can actually do about it.

The Boardroom Blind Spot: How Sales and Marketing Misalignment Erodes EBITDA
Teresa Allan
Written by
Teresa Allan
7 min read

You've reviewed the pipeline. You've heard the forecasts. And yet, quarter after quarter, you're explaining to the board why revenue is short of where it should be. The sales team blames the quality of leads. Marketing blames the sales team for not working them. Both are partially right. Neither is solving the real problem.

Sales and marketing misalignment sits at the heart of your business as a structural revenue problem. Most CEOs don't recognise it clearly until they're already in a P&L conversation they don't want to be having.

The gap nobody measures until it's too late

Most B2B businesses have two commercial engines running on separate fuel. Marketing generates demand and declares success by volume: leads, clicks, MQLs. Sales converts demand and declares success by closed revenue. Between those two definitions of winning, there's a gap. Prospects fall in. Deals stall. Campaigns run that the sales team ignores. And the cumulative drag on revenue compounds quietly.

CEOs often inherit this problem rather than create it. Growth through acquisition, organisational scaling, or a shift upmarket each create conditions where marketing and sales evolve separately: different KPIs, different leadership, different views of the customer. It works until it doesn't. And the point at which it stops working usually coincides with a growth plateau, a margin squeeze, or a board conversation about why commercial velocity has slowed.

The revenue impact is real and quantifiable. Misaligned teams create pipeline that looks healthy but isn't. SQLs that were never truly qualified. Proposals that go in at the wrong level. Re-work cycles that extend sales cycles. None of this shows up clearly in a single line on a dashboard, but it accumulates into material EBITDA drag.

What misalignment actually looks like at board level

There are three patterns that almost always indicate structural misalignment. All three manifest as revenue underperformance before they're diagnosed correctly.

The first is pipeline quality collapse. The ratio of deals entered to deals closed deteriorates, but incrementally. Sales leaders attribute it to market conditions or customer caution. Marketing attributes it to sales execution. The actual cause goes unexamined because neither team owns the handoff: leads that were never properly qualified, or sales plays that don't match buyer readiness.

The second is campaign irrelevance. Marketing runs campaigns that sales teams barely use. Collateral is produced that doesn't map to actual objections. Events are attended that generate no commercial follow-through. The cause is structural: marketing is optimising for a buyer journey model that sales isn't using in the room. The wasted investment is real. The opportunity cost of the campaigns that could have run instead is larger.

The third pattern is customer confusion at the point of sale. When marketing has positioned the business one way and sales has adapted the story differently for each prospect, buyers receive inconsistent signals. In enterprise B2B, inconsistency is a trust problem. It slows decisions. It invites more scrutiny. It opens the door to competitors who communicate more clearly.

Why standard fixes don't fix it

The reflex response of better communication, more cross-functional meetings, and shared dashboards treats misalignment as a relationship problem. The real issue is architectural.

Sales and marketing stay misaligned when they report separately, when their incentives diverge at the point they should converge, and when there's no single commercial owner accountable for the full journey from demand generation to closed revenue. Putting the CMO and CRO in the same room more often doesn't resolve the structural tension if their mandates still point in different directions.

The CEO has to own this diagnosis. Not delegate it. The right question to ask is whether sales and marketing have a shared definition of a good customer, a shared view of how we win, and shared accountability for the commercial outcome. In most businesses with a misalignment problem, the honest answer to at least one of those is no.

The commercial architecture that changes outcomes

Alignment is about precision, not harmony. The businesses that get this right build commercial architecture around three things.

A shared ICP with teeth. Not a generic description of an ideal customer, but a specific, agreed view of which customers are genuinely winnable, what triggers their buying decisions, and what a good deal looks like. This becomes the filter for both campaign targeting and sales qualification, eliminating the category of "leads that looked right but weren't."

A revenue-accountable handoff. The point at which marketing passes a prospect to sales should be defined in commercial terms, not activity terms. Not "attended a webinar" but "has a problem we solve, has budget ownership, and is within three months of a decision." When that definition is jointly owned and jointly reviewed, both teams have a stake in getting it right.

A single view of commercial velocity. Pipeline stage conversion, time-in-stage, and win rate by segment should be metrics that marketing and sales own together, reviewed together, and are rewarded against together. Not as a collaboration initiative, but as a commercial operating model.

The CEO decision that changes this

Fixing sales and marketing misalignment requires a structural decision, not a project plan. It requires the CEO to ask, and honestly answer, whether the current commercial architecture is designed to produce the revenue performance the business needs.

That means examining reporting lines, incentive structures, and the metrics that get airtime in commercial reviews. It means being willing to consolidate accountability in ways that feel uncomfortable for the leaders affected. And it means treating the gap between sales and marketing not as a people problem to be managed around, but as a structural risk to be resolved.

The businesses that close this gap deliberately, with executive authority behind the change, see shorter sales cycles, higher win rates, and better NRR. Not because their people suddenly get along better. Because the system stops working against them.

The gap between sales and marketing is a design choice. Most businesses arrive at it by default rather than intention. For a CEO managing a complex B2B commercial engine, the cost of that default is real: slower growth, avoidable pipeline waste, and an EBITDA drag that rarely gets its own line in the review. Closing it requires structural authority, not a working group. The first step is an honest audit of where your commercial architecture breaks down, before your next board conversation forces the question.

Ready to identify where misalignment is costing your business? Speak to the Magnus team about our commercial diagnostic.

Ready to move from thinking to doing?

The first conversation is always about your commercial challenge.

Tell us what you're working on. We'll tell you honestly whether Magnus can help - and what that would look like.

Start the conversation See growth stories